These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The application of serum tumor markers in the diagnosis of hepatocellular carcinoma]. Liao HY Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):379-80. PubMed ID: 15918977 [No Abstract] [Full Text] [Related]
3. Alpha-fetoprotein and hepatocellular carcinoma. Colli A; Fraquelli M; Conte D Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257 [No Abstract] [Full Text] [Related]
4. [Nonspecific tumor markers in hepatocellular carcinoma]. Stanciu L; Dumitraşcu D; Radu D; Badea R; Petcovici M; Ioniţă A; Szabo P; Pascu O Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(5):443-9. PubMed ID: 2473509 [No Abstract] [Full Text] [Related]
5. [Des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma]. Yamashiki M; Kosaka Y Rinsho Byori; 1989 Feb; 37(2):118-21. PubMed ID: 2471846 [No Abstract] [Full Text] [Related]
6. [Alpha-fetoprotein and its fucosylation index in the early diagnosis of hepatocellular carcinoma]. Aoyagi Y; Mita Y; Kuroiwa T; Wakuri N; Kawai H; Kobayashi M; Igarashi M; Suda T Nihon Rinsho; 2001 Oct; 59 Suppl 6():342-8. PubMed ID: 11761969 [No Abstract] [Full Text] [Related]
8. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis]. Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618 [No Abstract] [Full Text] [Related]
9. Alpha-2 macroglobulin: an additional marker for diagnosis of hepatocellular carcinoma. Kar P; Gandhi BM; Irshad M; Gupta H; Tandon BN J Assoc Physicians India; 1987 Apr; 35(4):288-9. PubMed ID: 2443479 [No Abstract] [Full Text] [Related]
10. [Clinical signification and evaluation of PIVKA-II in hepatocellular carcinoma]. Matsushima A; Enomoto M; Yokoo Y; Arai M; Kobayashi T; Okuno F; Hirano Y; Sujita K; Eto S; Takagi T Rinsho Byori; 1989 Jun; 37(6):683-6. PubMed ID: 2477568 [No Abstract] [Full Text] [Related]
11. Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B. Wong CB; Attar BM; Shimoda SS Am J Gastroenterol; 1995 Jun; 90(6):1015-6. PubMed ID: 7539578 [No Abstract] [Full Text] [Related]
12. [Cutaneous metastases of hepatocarcinoma]. Pérez MM; Puig L; Orobitg J; Conangla M; de Moragas JM Rev Clin Esp; 1988 Jun; 183(1):50-1. PubMed ID: 2459734 [No Abstract] [Full Text] [Related]
13. Screening of patients with chronic liver disease for hepatocellular carcinoma by ultrasonography. Okazaki N; Yoshida T; Yoshino M; Matue H Clin Oncol; 1984 Sep; 10(3):241-6. PubMed ID: 6206972 [TBL] [Abstract][Full Text] [Related]
14. Assay of serum A1-antitrypsin activity for the diagnosis of primary hepato-cellular carcinoma. Xu SK; Guan SF; Wang PL; Chen FH; Yu EX; Xu HQ Chin Med J (Engl); 1983 Aug; 96(8):607-10. PubMed ID: 6196162 [No Abstract] [Full Text] [Related]
15. [Tumor markers of hepatocellular carcinoma]. Kubo S; Matsukawa M Gan To Kagaku Ryoho; 2004 Dec; 31(13):2203-6. PubMed ID: 15628773 [TBL] [Abstract][Full Text] [Related]
16. Screening for hepatocellular carcinoma. Haydon GH; Hayes PC Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):856-60. PubMed ID: 8889450 [TBL] [Abstract][Full Text] [Related]
18. [Diagnosis of hepatocellular carcinoma performed by searching for serologic tumor markers]. de Oliveira e Silva A; Roldan-Molina F; dos Santos TE; Santo GC; Miranda MP; Genzini T; Neves LB; D'Albuquerque LA Arq Gastroenterol; 1990; 27(2):83-94. PubMed ID: 1709803 [TBL] [Abstract][Full Text] [Related]